TRACON Pharmaceuticals (NASDAQ:TCON) Now Covered by StockNews.com
Research analysts at StockNews.com began coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Get Free Report) in a report released on Sunday. The firm set a “strong-buy” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright lowered their price target on shares of TRACON Pharmaceuticals from $7.00 to $6.00 and set a “buy” rating on […]
More Stories
Knight Therapeutics (OTCMKTS:KHTRF) Trading 5.2% Higher – Here’s Why
Knight Therapeutics Inc. (OTCMKTS:KHTRF – Get Free Report)’s stock price traded up 5.2% on Tuesday . The company traded as...
Analyzing SBA Communications (NASDAQ:SBAC) & TPG RE Finance Trust (NYSE:TRTX)
SBA Communications (NASDAQ:SBAC – Get Free Report) and TPG RE Finance Trust (NYSE:TRTX – Get Free Report) are both finance...
Halma (OTCMKTS:HLMAF) Stock Price Up 0.6% – Time to Buy?
Shares of Halma plc (OTCMKTS:HLMAF – Get Free Report) traded up 0.6% during mid-day trading on Tuesday . The company...
New Commerce Split Fund (TSE:YCM) Shares Down 3.6% – Here’s What Happened
New Commerce Split Fund (TSE:YCM – Get Free Report)’s stock price traded down 3.6% on Tuesday . The company traded...
Borders & Southern Petroleum (LON:BOR) Trading Down 6.3% – Should You Sell?
Borders & Southern Petroleum plc (LON:BOR – Get Free Report) dropped 6.3% during trading on Tuesday . The stock traded...
Evonik Industries (FRA:EVK) Shares Up 1.5% – Should You Buy?
Evonik Industries AG (FRA:EVK – Get Free Report) shot up 1.5% on Tuesday . The company traded as high as...